Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has
been filed against Cigna Corp. (“Cigna” or the “Company”) (NYSE: CI).
Investors who purchased or otherwise acquired shares between February
27, 2014 and January 21, 2016, inclusive (the “Class Period”), are
encouraged to contact the Firm prior to the April 6, 2016, lead
plaintiff motion deadline.
If you purchased shares of Cigna during the Class Period, please contact
Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd
Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.
There has been no class certification in this case. Until certification
occurs, you are not represented by an attorney. You may choose to take
no action and remain a passive class member.
According to the complaint, the Company made misleading statements
and/or failed to disclose that: (1) its appeals and grievances
procedures were not compliant with federal standards; and (2) Cigna's
noncompliance with federal standards posed a serious threat to the
health and safety of Medicare beneficiaries.
If you purchased shares of Cigna during the Class Period, you have until
April 6, 2016 to ask the Court to appoint you as lead plaintiff. If you
wish to learn more about this lawsuit, or if you have any questions
concerning this notice or your rights, please contact Joon M. Khang, a
prominent litigator for almost two decades, by telephone: (949)
419-3834, or by email at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160314006372/en/
Copyright Business Wire 2016